☆ 4.6 Article

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping

DIAGNOSTICS (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma

Gerard J. Chu et al.

Summary: This study aimed to assess the intensity and distribution of MSLN immunostaining in mesothelioma and determine its prognostic value. The results showed that MSLN expression was more heterogeneous in epithelioid mesothelioma, suggesting the need for immunohistochemical assessment to stratify and assess patient suitability for personalized therapies targeting MESOTELIN.

HISTOPATHOLOGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy

Thomas Hager et al.

Summary: Malignant pleural mesothelioma (MPM) is a deadly asbestos-related tumor with limited treatment options. This study examines the expression of two proteins, MSLN and CXCR4, in MPM tumor samples and their potential as targets for endo-radioligand therapy. The results show significant expression of these proteins in a majority of the samples, suggesting the possibility of using radioligand-based diagnostics and endo-radiotherapy for MPM patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Oncology

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

Hedy L Kindler et al.

LANCET ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers

Rossella Bruno et al.

Summary: The study aimed to identify markers for biphasic pleural mesothelioma (PM) in order to improve subtyping and prognosis definition. By comparing the expression levels of cancer genes in the three major histotypes and evaluating the expression differences within biphasic PM, potential markers for diagnosis and prognostic stratification were identified.

DIAGNOSTICS (2022)

Add to Collection

Article Oncology

Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma

Chenglu He et al.

Summary: The study investigated the relationship between low CFB expression levels and clinical features in patients with LUAD. High levels of CFB were associated with increased overall and disease-free survival in LUAD patients. Multivariate analysis confirmed that high CFB expression was an independent predictor of improved overall and disease-free survival.

ONCOLOGY LETTERS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors

Soren Weidemann et al.

Summary: Analysis of MSLN expression in 15,050 tumors identified numerous important cancer types with high-level expression, indicating potential benefits from future anti-MSLN therapies. However, the prognostic relevance of MSLN appears to be limited.

BIOMEDICINES (2021)

Add to Collection

Article Oncology

Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer

Reiri Shimazaki et al.

Summary: The study identified complement factor B (CFB) as a key secreted protein involved in the progression of PDAC, promoting cellular proliferation and immunological tumor promotion. High stromal CFB expression was associated with unfavorable clinical outcomes in PDAC patients, indicating CFB may be a potential therapeutic target.

CELLULAR ONCOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma

Masayuki Watanabe et al.

Summary: This study identified claudin-15 as a potential positive marker for malignant pleural mesotheliomas, with high expression levels in 83% of MPM tissue samples. The specificity of CLDN15 was comparable to other markers in lung adenocarcinoma sections. CLDN15 showed low expression in non-mesothelial tumors, suggesting its potential clinical utility for MPM diagnosis.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Oncology

Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma

Fraser Brims

Summary: Mesothelioma is a cancer of the lining of the lungs caused by breathing in asbestos fibres, which remains a challenge in terms of treatment and has an uncertain survival time. The disease mainly occurs in males, with a clear risk associated with exposure to asbestos. There have been significant advances in diagnosis, but further research and treatment are still needed.

CANCERS (2021)

Add to Collection

Article Cell Biology

Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer

Danfang Zhang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Add to Collection

Article Pathology

The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas

Sarita Prabhakaran et al.

HUMAN PATHOLOGY (2020)

Add to Collection

Article Respiratory System

Pathology of Malignant Pleural Mesothelioma

Yin P. Hung et al.

THORACIC SURGERY CLINICS (2020)

Add to Collection

Article Oncology

Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer

Bruno Maerkl et al.

BMC CANCER (2019)

Add to Collection

Article Oncology

Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma

Lucian R. Chirieac et al.

CANCER (2019)

Add to Collection

Article Medicine, General & Internal

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

Nicolas Alcala et al.

EBIOMEDICINE (2019)

Add to Collection

Article Multidisciplinary Sciences

Senescence-associated reprogramming promotes cancer stemness

Maja Milanovic et al.

NATURE (2018)

Add to Collection

Article Medical Laboratory Technology

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Aliya Noor Husain et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)

Add to Collection

Editorial Material Cell Biology

Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse

Zhixun Dou et al.

CELL METABOLISM (2018)

Add to Collection

Article Medical Laboratory Technology

Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma Ten Years of Clinical Experience in Relation to International Guidelines

Anders Hjerpe et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)

Add to Collection

Article Oncology

Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival

Vivek Verma et al.

CLINICAL LUNG CANCER (2018)

Add to Collection

Article Oncology

Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis

David B. Nelson et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Oncology

Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma

Baoqing Tian et al.

ONCOTARGET (2017)

Add to Collection

Article Oncology

Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma

Shingo Inaguma et al.

ONCOTARGET (2017)

Add to Collection

Review Oncology

The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis

Daniel Brungs et al.

ONCOTARGET (2017)

Add to Collection

Article Biochemistry & Molecular Biology

PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer

Xian Lin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Add to Collection

Article Immunology

Prognostic value of p21-activated kinase 4 in resected pancreatic cancer

Sehhoon Park et al.

APMIS (2017)

Add to Collection

Article Oncology

Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma

Yusuke Takayama et al.

CANCER RESEARCH (2016)

Add to Collection

Article Oncology

NCCN Guidelines® Insights Malignant Pleural Mesothelioma, Version 3.2016 Featured Updates to the NCCN Guidelines

David S. Ettinger et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)

Add to Collection

Article Genetics & Heredity

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

Raphael Bueno et al.

NATURE GENETICS (2016)

Add to Collection

Article Oncology

Tumoral CD10 Expression Correlates with Aggressive Histology and Prognosis in Patients with Malignant Pleural Mesothelioma

Kyuichi Kadota et al.

ANNALS OF SURGICAL ONCOLOGY (2015)

Add to Collection

Article Oncology

Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion

Songwang Cai et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)

Add to Collection

Article Surgery

P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration

Bao Song et al.

JOURNAL OF SURGICAL RESEARCH (2015)

Add to Collection

Article Oncology

Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients

Danni Li et al.

TUMOR BIOLOGY (2015)

Add to Collection

Article Urology & Nephrology

p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma

Weisi Liu et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)

Add to Collection

Article Oncology

Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis

Sebastien Tabaries et al.

ONCOTARGET (2015)

Add to Collection

Article Oncology

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

Giulia Pasello et al.

ONCOTARGET (2015)

Add to Collection

Article Oncology

Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study

L. Capkova et al.

NEOPLASMA (2014)

Add to Collection

Article Pathology

Mesothelioma with signet-ring cell features: report of 23 cases

Nelson G. Ordonez

MODERN PATHOLOGY (2013)

Add to Collection

Article Oncology

Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysis

Roy Sidi et al.

EUROPEAN JOURNAL OF CANCER (2011)

Add to Collection

Article Pathology

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry

Helmut P. Sandeck et al.

DIAGNOSTIC PATHOLOGY (2010)

Add to Collection

Article Pathology

Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter

Ke Tan et al.

HUMAN PATHOLOGY (2010)

Add to Collection

Article Pathology

Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases

Sonja Klebe et al.

MODERN PATHOLOGY (2010)

Add to Collection

Article Oncology

Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma

Asma Begum et al.

CANCER SCIENCE (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.